Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | ADCT | MGTX | ||
| Company | Urogen Pharma Ltd | Adc Therapeutics Sa | Meiragtx Holdings Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 14.86 | 4.33 | 5.40 | ||
| High | 15.05 | 4.60 | 5.52 | ||
| Low | 14.15 | 4.30 | 5.37 | ||
| Last | 14.49 | 4.44 | 5.41 | ||
| Change | -0.61 | +0.07 | -0.06 | ||
| % Change | -4.04% | +1.60% | -1.10% | ||
| Volume | 409,956 | 208,672 | 128,564 | ||
| 20-Day Average Volume | 452,098 | 474,144 | 141,053 | ||
| Previous Close | 15.10 | 4.37 | 5.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.46 | 4.56 | 5.86 | ||
| 20-Day Raw Stochastic | 36.18% | 28.24% | 4.38% | ||
| 20-Day Relative Strength | 46.09% | 51.20% | 41.38% | ||
| Weighted Alpha | -26.77 | +36.86 | -46.41 | ||
| Today's Opinion | 24% Sell | 72% Buy | 24% Sell | ||
| Previous Opinion | 8% Buy | 72% Buy | 24% Sell | ||
| Last Month's Opinion | 8% Buy | 80% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.38% since 04/09/24 | -7.11% since 04/09/24 | -5.42% since 04/09/24 | ||
| Low | 12.37 on 04/11/24 | 4.11 on 04/15/24 | 5.37 on 04/16/24 | ||
| High | 15.50 on 04/15/24 | 4.86 on 04/11/24 | 5.79 on 04/11/24 | ||
| 1-Month | |||||
| %Chg | +0.21% since 03/15/24 | +17.46% since 03/15/24 | -14.80% since 03/15/24 | ||
| Low | 12.37 on 04/11/24 | 3.70 on 03/18/24 | 5.35 on 04/03/24 | ||
| High | 18.23 on 03/25/24 | 5.38 on 04/08/24 | 6.85 on 03/18/24 | ||
| 3-Month | |||||
| %Chg | -1.23% since 01/16/24 | +136.17% since 01/16/24 | -11.75% since 01/16/24 | ||
| Low | 12.37 on 04/11/24 | 1.71 on 01/19/24 | 5.35 on 04/03/24 | ||
| High | 19.87 on 02/16/24 | 6.04 on 02/20/24 | 6.93 on 01/26/24 | ||
| 6-Month | |||||
| %Chg | +10.86% since 10/16/23 | +462.03% since 10/16/23 | +23.23% since 10/16/23 | ||
| Low | 10.63 on 10/30/23 | 0.36 on 11/13/23 | 3.49 on 10/25/23 | ||
| High | 19.87 on 02/16/24 | 6.04 on 02/20/24 | 7.60 on 12/26/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 354,155 | 360,656 | 351,267 | ||
| Shares Outstanding, K | 23,454 | 82,530 | 64,217 | ||
| Annual Sales | 82,710,000 | 69,560,000 | 14,020,000 | ||
| Annual Net Income | -102,240,000 | -240,050,000 | -84,030,000 | ||
| Last Quarter Sales | 23,530,000 | 16,790,000 | 2,040,000 | ||
| Last Quarter Net Income | -26,020,000 | -85,700,000 | 20,220,000 | ||
| 60-Month Beta | 1.07 | 1.73 | 1.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/14/24 | -1.03 on 03/13/24 | -0.47 on 03/14/24 | ||
| Latest Earnings Date | 05/09/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||